Ankerstar Wealth’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212 Hold
19
– – ﹤0.01% 924
2026
Q2
$194 Hold
19
– – ﹤0.01% 891
2026
Q1
$170 Hold
19
– – ﹤0.01% 870
2025
Q4
$115 Buy
+19
New +$113 ﹤0.01% 993

Other funds holding VIR

Ankerstar Wealth's VIR Position: Q3 2026 in Review

Ankerstar Wealth held its Vir Biotechnology (VIR) position steady in Q3 2026 at 19 shares worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Ankerstar Wealth first reported a position in VIR in Q4 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Ankerstar Wealth held 19 shares of Vir Biotechnology worth $212 as of Q3 2026.
  • Ankerstar Wealth left its Vir Biotechnology share count unchanged in Q3 2026.
  • Vir Biotechnology made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #924 holding.
  • Ankerstar Wealth first reported a position in Vir Biotechnology in Q4 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.